Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total		Common Stock	Additional Paid-in Capital		Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Feb. 02, 2020				77,137,000
Beginning balance at Feb. 02, 2020		$ 1,235,860		$ 772	$ 605,822		$ 644,794	$ (14,587)	$ (941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		680,714					680,714
Foreign currency translation adjustments		8,195						8,195
Change in fair value of derivative financial instruments, net of tax		(315)						(315)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(410)						(410)
Conversion/release of stock-based awards (in shares)	[1]			699,000
Conversion/release of stock-based awards	[1]	(31,729)		$ 7	(31,565)				(171)
Repurchases of common stock (in shares)				(1,496,000)
Repurchases of common stock		(150,000)		$ (15)	(7,569)		(142,416)
Reissuance of treasury stock under stock-based compensation plans		0	[1]		(499)	[1]	(14)		513	[1]
Stock-based compensation expense		72,186			72,186
Dividends declared		(163,316)					(163,316)
Ending balance (in shares) at Jan. 31, 2021				76,340,000
Ending balance at Jan. 31, 2021		1,651,185		$ 764	638,375		1,019,762	(7,117)	(599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		1,126,337					1,126,337
Foreign currency translation adjustments		(4,488)						(4,488)
Change in fair value of derivative financial instruments, net of tax		(247)						(247)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		1,024						1,024
Conversion/release of stock-based awards (in shares)	[1]			745,000
Conversion/release of stock-based awards	[1]	(104,235)		$ 7	(103,742)				(500)
Repurchases of common stock (in shares)				(5,103,000)
Repurchases of common stock		(899,433)		$ (51)	(26,806)		(872,576)		0
Reissuance of treasury stock under stock-based compensation plans	[1]	0			(344)		(44)		388
Stock-based compensation expense		93,459			93,459
Dividends declared		$ (199,395)					(199,395)
Ending balance (in shares) at Jan. 30, 2022		71,982,000		71,982,000
Ending balance at Jan. 30, 2022		$ 1,664,207		$ 720	600,942		1,074,084	(10,828)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		1,127,904					1,127,904
Foreign currency translation adjustments		(3,572)						(3,572)
Change in fair value of derivative financial instruments, net of tax		932						932
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(341)						(341)
Conversion/release of stock-based awards (in shares)	[1]			668,000
Conversion/release of stock-based awards	[1]	(81,290)		$ 7	(80,925)				(372)
Repurchases of common stock (in shares)				(6,424,000)
Repurchases of common stock		(880,038)		$ (64)	(36,134)		(843,840)
Reissuance of treasury stock under stock-based compensation plans	[1]	0			(344)		0		344
Stock-based compensation expense		89,578			89,578
Dividends declared		$ (216,329)					(216,329)
Ending balance (in shares) at Jan. 29, 2023		66,226,000		66,226,000
Ending balance at Jan. 29, 2023		$ 1,701,051		$ 663	$ 573,117		$ 1,141,819	$ (13,809)	$ (739)

[1] Amounts are shown net of shares withheld for employee taxes.